Cargando…
Anti-tumour activity of bisphosphonates in preclinical models of breast cancer
There is increasing evidence of anti-tumour effects of bisphosphonates from pre-clinical studies, supporting a role for these drugs beyond their traditional use in treatment of cancer-induced bone disease. A range of model systems have been used to investigate the effects of different bisphosphonate...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046431/ https://www.ncbi.nlm.nih.gov/pubmed/21176176 http://dx.doi.org/10.1186/bcr2769 |